Skip to Content
News & Insights
In a recent Law360 Expert Analysis, Cameron Turner shared insights on the recent opioid litigation surrounding Purdue Pharma. Please click here for the June 17 piece.
DO NOT SEND CONFIDENTIAL INFORMATION.
This website presents general information about Segal McCambridge and is not intended as legal advice, nor should you consider it as such. You should not act upon this information without seeking professional counsel. By clicking “Accept terms” you acknowledge that you understand that merely contacting Segal McCambridge will not establish an attorney-client relationship. Segal McCambridge cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement Accordingly, please do not send Segal McCambridge any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and you get authorization in the form of an engagement letter from Segal McCambridge. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature.